{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:54:31Z","timestamp":1778864071873,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010892","name":"Department of Science and Technology","doi-asserted-by":"crossref","award":["DST\/SJF\/LSA-02\/2014-15"],"award-info":[{"award-number":["DST\/SJF\/LSA-02\/2014-15"]}],"id":[{"id":"10.13039\/501100010892","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ajp.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T13:01:52Z","timestamp":1492174912000},"page":"142-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clozaphobia: Is avoidance of clozapine in diabetes warranted?"],"prefix":"10.1016","volume":"28","author":[{"given":"Vanteemar S.","family":"Sreeraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-8168","authenticated-orcid":false,"given":"Damodaran","family":"Dinakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Nagendrappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naren P.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muralidaran","family":"Kesavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivarama","family":"Varambally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-898X","authenticated-orcid":false,"given":"Ganesan","family":"Venkatasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2017.04.005_bib0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881116645254","article-title":"BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment","volume":"30","author":"Cooper","year":"2016","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.ajp.2017.04.005_bib0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pnpbp.2005.04.031","article-title":"Does clozapine decrease smoking?","volume":"29","author":"de Leon","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2017.04.005_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7326\/0003-4819-157-7-201210020-00525","article-title":"Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis","volume":"157","author":"Hartling","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ajp.2017.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00002018-200225150-00005","article-title":"Glucose intolerance with atypical antipsychotics","volume":"25","author":"Hedenmalm","year":"2002","journal-title":"Drug Saf."},{"issue":"Suppl. 1","key":"10.1016\/j.ajp.2017.04.005_bib0025","first-page":"S423","article-title":"What evidence is there to show which antipsychotics are more diabetogenic than others?","volume":"27","author":"Jesus","year":"2015","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.ajp.2017.04.005_bib0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0002-9343(01)01000-2","article-title":"Clozapine-associated diabetes","volume":"111","author":"Koller","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ajp.2017.04.005_bib0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mehy.2012.12.024","article-title":"Increasing the clozapine:norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy","volume":"80","author":"Legare","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"February (Suppl. 2)","key":"10.1016\/j.ajp.2017.04.005_bib0040","first-page":"1","article-title":"American Psychiatric Association and Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajp.2017.04.005_bib0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders \u2013 a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2017.04.005_bib0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists\u2019 attitude towards and knowledge of clozapine treatment","volume":"24","author":"Nielsen","year":"2010","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.ajp.2017.04.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-016-4411-x","article-title":"Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports","author":"Polcwiartek","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ajp.2017.04.005_bib0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/JCP.0000000000000465","article-title":"Risk of new-onset diabetes after long-term treatment with clozapine in comparison to other antipsychotics in patients with schizophrenia","volume":"36","author":"Schulte","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2017.04.005_bib0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1192\/bjp.202.2.154b","article-title":"Delay in starting clozapine and treatment guidelines","volume":"202","author":"Sharma","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2017.04.005_bib0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2017.04.005_bib0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2045125316649534","article-title":"Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject","volume":"6","author":"Tungaraza","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2017.04.005_bib0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2045125314566808","article-title":"Clozapine prescribing in the UK: views and experience of consultant psychiatrists","volume":"5","author":"Tungaraza","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201817301478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201817301478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:29:42Z","timestamp":1761755382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201817301478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":16,"alternative-id":["S1876201817301478"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2017.04.005","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozaphobia: Is avoidance of clozapine in diabetes warranted?","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}